Hepatocellular carcinoma: Difference between revisions
Line 18: | Line 18: | ||
==[[Classification]]== | ==[[Classification]]== | ||
__NOTOC__ | |||
{{Xyz}} | |||
{{CMG}}; {{AE}} | |||
==Overview== | |||
There is no established system for the classification of [disease name]. | |||
OR | |||
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4]. | |||
OR | |||
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. | |||
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3]. | |||
OR | |||
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic. | |||
OR | |||
If the staging system involves specific and characteristic findings and features: | |||
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2]. | |||
OR | |||
The staging of [malignancy name] is based on the [staging system]. | |||
OR | |||
There is no established system for the staging of [malignancy name]. | |||
==Classification== | |||
*There is no established system for the classification of [disease name]. | |||
OR | |||
*[Disease name] may be classified according to [classification method] into [number] subtypes/groups: | |||
**[Group1] | |||
**[Group2] | |||
**[Group3] | |||
**[Group4] | |||
OR | |||
*[Disease name] may be classified into [large number > 6] subtypes based on: | |||
**[Classification method 1] | |||
**[Classification method 2] | |||
**[Classification method 3] | |||
*[Disease name] may be classified into several subtypes based on: | |||
**[Classification method 1] | |||
**[Classification method 2] | |||
**[Classification method 3] | |||
OR | |||
*Based on the duration of symptoms, [disease name] may be classified as either acute or chronic. | |||
OR | |||
*If the staging system involves specific and characteristic findings and features: | |||
*According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2]. | |||
OR | |||
*The staging of [malignancy name] is based on the [staging system]. | |||
OR | |||
*There is no established system for the staging of [malignancy name]. | |||
==References== | |||
{{Reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
[[Category: (name of the system)]] | |||
==Overview== | ==Overview== |
Revision as of 04:56, 19 December 2017
Hepatocellular carcinoma | |
Hepatocellular Carcinoma, Hepatitis C positive. Tumor growth in portal vein |
Hepatocellular carcinoma Microchapters |
Differentiating Hepatocellular carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hepatocellular carcinoma On the Web |
American Roentgen Ray Society Images of Hepatocellular carcinoma |
Risk calculators and risk factors for Hepatocellular carcinoma |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Synonyms and keywords: Hepatoma; malignant hepatoma; liver cancer; malignant liver tumor; primary liver cell carcinoma; hepatic cancer
Overview
Historical perspective
Classification
Xyz Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hepatocellular carcinoma On the Web |
American Roentgen Ray Society Images of Hepatocellular carcinoma |
Risk calculators and risk factors for Hepatocellular carcinoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-in-Chief:
Overview
There is no established system for the classification of [disease name].
OR
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
OR
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].
Classification
- There is no established system for the classification of [disease name].
OR
- [Disease name] may be classified according to [classification method] into [number] subtypes/groups:
- [Group1]
- [Group2]
- [Group3]
- [Group4]
OR
- [Disease name] may be classified into [large number > 6] subtypes based on:
- [Classification method 1]
- [Classification method 2]
- [Classification method 3]
- [Disease name] may be classified into several subtypes based on:
- [Classification method 1]
- [Classification method 2]
- [Classification method 3]
OR
- Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
- If the staging system involves specific and characteristic findings and features:
- According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
- The staging of [malignancy name] is based on the [staging system].
OR
- There is no established system for the staging of [malignancy name].
References
Overview
There is no established system for the classification of [disease name].
OR
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
OR
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].
Pathophysiology
Causes
Differentiating Hepatocellular carcinoma from other Diseases
Epidemiology & Demographics
Risk factors
Screening
Natural History, Complications & Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Lab Studies | Electrocardiogram | Chest X Ray | MRI | CT | Ultrasound | Other imaging findings | Other diagnostic studies
Treatment
Medical Therapy | Surgery | Primary prevention | Secondary prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
References
Template:Gastroenterology
Template:Tumors
Template:Tumor morphology